Discontinuation report CLAVULIN 875
Report ID | 216509 |
Drug Identification Number | 02238829 |
Brand name | CLAVULIN 875 |
Common or Proper name | amoxicillin / clavulanate potassium tablets |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
Strength(s) | 125MG 875MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | All pack sizes / Tous les formats |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-01-13 |
Remaining supply date | 2025-06-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-01-18 | English | Compare |
v2 | 2024-01-18 | French | Compare |
Showing 1 to 2 of 2